Growth Control and Cancer

, Monika Hassel2 and Maura Grealy3



(1)
Centre of Organismal Studies, University of Heidelberg, Heidelberg, Germany

(2)
Spezielle Zoologie, Universität Marburg FB Biologie, Marburg, Germany

(3)
Pharmacology and Therapeutics, National University of Ireland Galway, Galway, Ireland

 



Of all diseases, cancer is perhaps the most relevant to the study of developmental biology since it represents alterations in otherwise normal processes of growth. Growth is defined as increase in mass. Growth can result from more than one process. For example, enlargement of individual cells is a cause of growth. Muscle fibres grow by expanding in length and diameter. Also, the deposition of extracellular matrix material contributes to enlargement of the growing juvenile. However, most increase in mass is based on cell division followed by the enlargement of the daughter cells to the size characteristic of the cell type. In the following growth is understood as increase in cell number, not in cell size or individual cell mass.

Increase in cell number can result from the activity of certain ‘oncogenes’ (from the Greek oncos = mass and genein = to generate), and such an increase can be dangerous as it can result in the formation of a tumour.


19.1 Growth Control



19.1.1 Multicellular Living Beings as a Whole and the Size of all Their Organs Are Subjected to Growth Control


In multicellular organisms the individual cells are subject to social control. Unlike free-living unicellular organisms, the members of a multicellular community must reduce or cease their multiplication at the right time and place. The process of terminal differentiation alone is associated with a delay in the cell cycle and thus causes a slowdown of cell multiplication. Frequently, terminal differentiation results in a complete cessation of growth. In mammals, for example, mature blood cells and nerve cells completely lose the ability to divide. Termination of growth in these cells is part of their normal developmental program. In contrast, stem cells and several types of progenitor cells must continue to divide.

Apoptosis, programmed cell death, terminates the life of individual cells in many cell types. Apoptosis was introduced in Chap. 14 (Fig. 14.​9) and will further be discussed in Chap. 21 (Ageing and Death) but must also be considered in theories on carcinogenesis.

Besides such endpoints programmed at the outset in the developmental progress cells remaining potentially immortal either self-regulate their proliferation rate or are controlled by their neighbours.


19.1.2 Cell Populations Self-control Their Multiplication Rate


A simple model provides a plausible indication of how a population can automatically constrict its growth itself. Imagine all cells of a still small and loosely arranged cell society produce inhibitory substances, be it trivial metabolic end products or specific negative growth factors; the substances are released into the surrounding interstitial diffusion space having restricted capacity. Initially the density of the population would be low and so also the concentration of the inhibitory substance. With increasing cell number more and more producers are active but the diffusion space around each individual cell will not increase but shrink resulting in a steep slope upwards in concentration of the inhibitor. Eventually a threshold will be reached above which growth comes to a standstill. In addition, in large massive organs such as the liver, outflow of inhibitory substances decreases with enlargement of the organ since in relation to mass and cell number the surface area decreases.


19.1.3 The Neighbourhood Also Intervenes in Growth Control


In the scientific literature there is only rarely talk of signalling substances preventing growth probably because often clear distinctions cannot be made. Many growth factors stimulates proliferation of certain cells at low concentration but stop it at high concentration. In precursor cells capable of dividing (indicated by the suffix ‘-blasts’), for example in the blood forming hemangioblasts, myeloblasts and erythroblasts (Chap. 18) some of these factors promote proliferation at low concentration but induce terminal differentiation at high concentration. Hence such proteins are called differentiation factors or differentiation hormones. Moreover, in a given case it is difficult or even impossible to discriminate between specific and non-specific inhibition. Growth inhibiting signalling substances are not always soluble factors. On the contrary, in most tissues cell adhesion molecules CAM and components of the extracellular matrix provide such signals. This is indicated by the behaviour of dissociated cells which in cell culture resume dividing upon separation from the social society, and shown by the behaviour of cancer cells.


19.2 Cancer: Essence, Incidence,Terms


“Cancer” is a collective term comprising more than 200 different diseases the common denominator of which is excessive growth of one or more cell types. If tumours result they may throttle the supply of other tissues, disrupt blood vessels and nerve fibres, or disrupt and break organs such as the skin (see Fig. 18.​2). About 25 % of the population of industrial countries will in the course of their life have to suffer complaints caused by apparent or concealed tumours (In reading statistics one has to distinguish between incidence and mortality).

The behaviour of cancer cells can also be observed in cell culture.


19.2.1 Cancer Results from Disturbed Growth and Differentiation Control


Cancer arises when basic rules of the cell-specific or social control of proliferation are violated. Excessive multiplication may occur in the following situations:

1.

Progenitor cells multiply too rapidly or frequently. Terminal cell differentiation cannot cope with this excessive cell number and remove enough of the descendants from the pool of cells capable of dividing.

 

2.

Even if the cell cycle is not accelerated, uncontrolled growth can arise



  • when both daughters of a dividing stem cell retain the traits of stem cells. Normally, on average only one of two daughter cells retains the characteristics of a stem cell, while the other becomes committed to cell differentiation;


  • when differentiating cells do not stop dividing. Cell divisions continue, even when the program of differentiation is largely finished. For example, melanomas develop from nearly mature derivatives of neural crest cells which synthesize black melanin but nevertheless do not stop dividing;


  • when differentiated cells partly reembryonalize regaining capability to divide;


  • when cells are not eliminated by programmed cell death in time; this holds especially for mutated precursors of cancer cells that should subject themselves to suicide by apoptosis.

 


19.2.2 Glossary of Cancer Terms Reveals Which Cell Types Tend to Cancerous Growth


Transformation. The deterioration of a civilized cell into an antisocial cancer cell is called neoplastic transformation (Greek: neo = new; plastein = to form). Agents causing carcinogenesis are called carcinogenic (Latin/Greek: cancer-generating) or oncogenic (Greek: oncos = mass; genein = generating). However, the common use of the term ‘oncogene’ may be confusing. While the adjective oncogenic means “cancer generating”, the noun oncogene refers to a gene causing cancer.

A tumour (Latin = swelling) is an association of cancerous cells, generally deriving from one transformed founder cell. A tumour may be benign (Latin benignus = mild, good-natured) or malignant (Latin malignus = malicious, ill-natured). A tumour becomes malignant when cells migrate from the primary tumour to invade other tissues and establish colonies of secondary tumours, called metastases (Greek: meta = subsequent, stasis = location).

Depending on its origin, a tumour may be a



  • Carcinoma: a malignant tumour derived from epithelial tissue (Fig. 18.​2)


  • Adenoma: a benign tumour of epithelial origin and glandular appearance


  • Adenocarcinoma: a malignant tumour of glandular appearance


  • Sarcoma: derived from connective tissue


  • Hepatoma, hepatocarcinoma, arisen from hepatocytes or other liver cells


  • Melanoma: derived from melanocytes (pigment cells of the skin)


  • Neuroblastoma: derived from neuroblasts


  • Glioma: derived from glial cells (most brain tumours are gliomas)


  • Myoma: derived from myoblasts including satellite cells


  • Myeloma: derived from blood progenitor cells, in particular from myeloid stem cells


  • Lymphoma: derived from lymphoblasts


  • Leukaemias: derived from various, undefined blood progenitor cells but mostly from lymphoid stem cells and lymphoblasts (see Fig. 18.​6) but may also include immature erythroblasts.

Strikingly, tissues and cell types capable of self renewal and derived from stem cells suffer neoplastic transformation more frequently than others. Among them, carcinomas are the most frequent tumours. Epithelia contain many dividing stem cells in which mutations may disturb the mechanisms of control. In addition, epithelia are exposed to carcinogenic agentssuch as ultraviolet solar radiationto a particularly high degree.


19.3 Particular Features of Cancer Cells and Tumours



19.3.1 Cancer Cells Frequently Are Immortal, Independent of Growth Factors, and Evade Apoptosis


In cell culture cancer cells display behaviour that reveals their reluctance being controlled and they ignore social rules.

1.

Immortality. Cells of established cultures multiply as long as depletion of nutrients, available space and inhibitory metabolic products do not set limits. These cells do not age and retain the ability to divide. However, this holds not only for cancer cells. In vitro also non-transformed stem cells retain unlimited ability to divide, and established cell lines derive from stem cells or cells that regained features of stem cells. Transplanted into test animals immortal cell lines do not necessarily display uncontrolled growths, thus, immortality as such is not a sufficient criterion of cancerous deterioration.

 

2.

Independence of growth factors. Some cell lines produce their own growth factors (autocrine stimulation), or cells become completely independent of growth stimulating factors as are the cells of the early embryo during the phase of cleavage. Yet, if such cells did not originate from embryos but from suspicious swellings this independence can be a criterion of cancerous transformation. How such independence might be achieved is discussed in Sect. 19.4.

 

3.

Bypassing automatic self-destruction. In frequently repeating divisions the mechanisms for DNA repair occasionally do not fully comply with their task. Damage to DNA accumulates, or chromosomes are unequally distributed in cell division (aneuploidy). In such cases the cells should turn on the suicide program (apoptosis) or be forced by the immune system to undergo self-destruction. Cancer cells evade such demands. In other words, cells which escape the imprinted suicide program by chance, for instance because of mutations, proliferate in spite of internal damage.

 

4.

Absence of contact inhibition. Cancer cells display an unusual and selfish behaviour. Cancer cells neglect and ignore many social rules, for instance do not obey the rule of contact inhibition. Most cell types maintained in cell culture stop moving when they encounter other cells and stop dividing when they are completely surrounded by adjacent cells. Adhesiveness links the cells in a confluent monolayer. Cancer cells are different: they show persistent locomotion, crawl over their neighbours and continue to divide, producing foci (small cell clusters). Transformed cells are rounder in cross section, lack adhesion plaques and stress fibres, and are less covered with fibronectin. Such foci are sure signs of the presence of cancerous cells. The lack of contact inhibition is a prerequisite for the invasion of a tumour into healthy tissue and for the occurrence of metastases.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 31, 2016 | Posted by in GENERAL | Comments Off on Growth Control and Cancer

Full access? Get Clinical Tree

Get Clinical Tree app for offline access